Select Medical (NYSE:SEM) Issues Quarterly Earnings Results

Select Medical (NYSE:SEM) announced its quarterly earnings data on Thursday. The health services provider reported $0.18 EPS for the quarter, missing the consensus estimate of $0.29 by ($0.11), Zacks reports. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. Select Medical updated its FY 2025 guidance to 1.090-1.190 EPS.

Select Medical Price Performance

NYSE:SEM traded down $0.15 during mid-day trading on Thursday, hitting $19.11. 975,271 shares of the stock traded hands, compared to its average volume of 792,814. The business’s 50-day moving average price is $19.14 and its 200 day moving average price is $28.14. The company has a market cap of $2.47 billion, a PE ratio of 8.93, a price-to-earnings-growth ratio of 0.64 and a beta of 1.45. Select Medical has a 12-month low of $18.02 and a 12-month high of $40.98. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37.

Insider Activity at Select Medical

In related news, VP Robert G. Breighner, Jr. sold 4,989 shares of the business’s stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total transaction of $99,530.55. Following the completion of the transaction, the vice president now owns 30,356 shares of the company’s stock, valued at approximately $605,602.20. The trade was a 14.12 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Marilyn B. Tavenner sold 32,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total transaction of $674,880.00. Following the transaction, the director now directly owns 22,000 shares of the company’s stock, valued at approximately $463,980. This represents a 59.26 % decrease in their position. The disclosure for this sale can be found here. 19.14% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts have commented on SEM shares. StockNews.com lowered shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Thursday, February 13th. Royal Bank of Canada boosted their price target on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Benchmark lowered shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, November 25th. Finally, UBS Group lowered their price target on shares of Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a research report on Friday, January 3rd. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, Select Medical currently has a consensus rating of “Hold” and an average price target of $39.50.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.